ZBAI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
ZBAI is not a good buy right now. The trend is bearish (stacked bearish moving averages and weakening MACD), there are no supportive catalysts or bullish sentiment signals, and the latest quarter shows revenue growth but still deep losses and deteriorating EPS. Given an impatient approach and no proprietary buy signals today, the best action is to avoid/exit rather than buy.
Price/Trend: Bearish trend structure with SMA_200 > SMA_20 > SMA_5, indicating sustained downside momentum across long-, mid-, and short-term timeframes. Momentum: MACD histogram is negative (-0.0204) and negatively expanding, suggesting bearish momentum is strengthening rather than stabilizing. RSI: RSI_6 at ~34.5 is near the lower end of neutral (borderline oversold), but not showing a confirmed reversal signal. Levels: Pivot at 6.807 is overhead resistance; price (6.45) is below pivot, reinforcing bearish bias. Key support S1 ~6.246 (then S2 ~5.899). If S1 breaks, downside risk increases. Upside levels: R1 ~7.369 and R2 ~7.716, but a reclaim of the pivot is the first hurdle. Pattern-based odds: Similar-pattern projection shows weak near-term drift (-0.39% next week) with a more optimistic 1-month expectation (+8.07%), but that longer-horizon edge lacks confirmation from momentum/MA signals today.
Intellectia Proprietary Trading Signals
holds.
signal continuation risk.
Latest quarter: 2025/Q4. Growth: Revenue increased to $750,000 (+177.78% YoY), a strong top-line growth rate. Profitability: Net income fell to -$738,427 (reported as down -45.34% YoY) and EPS fell to -0.74 (-63.55% YoY), showing worsening per-share performance and continued losses. Margins: Gross margin listed as 100 (no YoY change), but despite margin stability, losses remain significant—suggesting operating costs/other expenses are pressuring results. Overall: Strong revenue growth but deteriorating bottom-line metrics; not the kind of quarter that typically supports an aggressive buy without a clear technical reversal or catalyst.
No analyst rating or price target change data provided, so there is no observable recent Wall Street upgrade/downgrade trend or consensus pros/cons view to rely on.
